Looking for Early Signs of Obesity Risk in Young Children
Looks for early biological markers of obesity risk in children up to 4.
Plain-language title generated from the registry record
Registry title: Childhood Obesity Risk Markers (MARIOBE)
Key facts
- Where
- Clermont-Ferrand, FranceSee the site
Where in France
- CHU de Clermont-FerrandClermont-Ferrand, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Clermont-Ferrand
- Trial code
- NCT07831291
- Record updated
- 21 September 2026
- Original description
Metabolic diseases, including childhood obesity, represent a major public health challenge. Studies in mice have identified transcriptomic markers in adipose tissue capable of predicting a predisposition to obesity prior to any weight gain. The MARIOBE project aims to translate this approach to young children (≤ 4 years old) in order to identify individual vulnerability to obesity at an early stage.Read full original descriptionShow less
Childhood Obesity Risk Markers
Metabolic diseases, including childhood obesity, represent a major public health challenge. Studies in mice have identified transcriptomic markers in adipose tissue capable of predicting a predisposition to obesity prior to any weight gain. The MARIOBE project aims to translate this approach to young children (≤ 4 years old) in order to identify individual vulnerability to obesity at an early stage.
Inclusion: Child scheduled for surgery allowing for the harvesting of adipose tissue.
Exclusion: Child whose holders of parental authority are protected by law.